These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16146770)

  • 1. Second-line intra-arterial chemotherapy in advanced pancreatic adenocarcinoma.
    Barletta E; Fiore F; Daniele B; Ottaiano A; D'Angelo R; Ferrari E; Formato R; Tortoriello A; Turitto G; Bruni GS; Pignata S; Iaffaioli RV
    Front Biosci; 2006 Jan; 11():782-7. PubMed ID: 16146770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience.
    Milandri C; Calzolari F; Passardi A; Tison C; Giampalma E; Cecconetto L; Golfieri R
    Hepatogastroenterology; 2007 Dec; 54(80):2373-7. PubMed ID: 18265668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial infusion of 5-fluorouracil, leucovorin, epirubicin and carboplatin (FLEC regimen) in unresectable pancreatic cancer: results of a ten-year experience.
    Mambrini A; Sanguinetti F; Pacetti P; Caudana R; Iacono C; Guglielmi A; Guadagni S; Del Freo A; Fiorentini G; Cantore M
    In Vivo; 2006; 20(6A):751-5. PubMed ID: 17203761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant intra-arterial 5-fluoruracil, leucovorin, epirubicin and carboplatin with or without systemic gemcitabine after curative resection for pancreatic adenocarcinoma.
    Cantore M; Serio G; Pederzoli P; Mambrini A; Iacono C; Pulica C; Capelli P; Lombardi M; Torri T; Pacetti P; Pagani M; Fiorentini G
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):504-8. PubMed ID: 16633830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.
    Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Rabbi C; Marangolo M
    J Chemother; 2004 Dec; 16(6):589-94. PubMed ID: 15700852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.
    Cantore M; Fiorentini G; Luppi G; Rosati G; Caudana R; Piazza E; Comella G; Ceravolo C; Miserocchi L; Mambrini A; Del Freo A; Zamagni D; Aitini E; Marangolo M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):51-7. PubMed ID: 16767907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-arterial chemotherapy for unresectable pancreatic cancer.
    Cantore M; Pederzoli P; Cornalba G; Fiorentini G; Guadagni S; Miserocchi L; Frassoldati A; Ceravolo C; Smerieri F; Muchmore JH
    Ann Oncol; 2000 May; 11(5):569-73. PubMed ID: 10907950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy.
    Mambrini A; Bassi C; Pacetti P; Torri T; Iacono C; Ballardini M; Orlandi M; Guadagni S; Fiorentini G; Cantore M
    Pancreas; 2008 Jan; 36(1):56-60. PubMed ID: 18192882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced pancreatic cancer with epirubicin, 5-fluorouracil and 1-leucovorin: a phase II study.
    Raderer M; Kornek GV; Hejna MH; Weinlaender G; Vorbeck F; Fiebiger WC; Scheithauer W
    Ann Oncol; 1997 Aug; 8(8):797-9. PubMed ID: 9332689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).
    André T; Noirclerc M; Hammel P; Meckenstock R; Landi B; Cattan S; Selle F; Codoul JF; Guerrier-Parmentier B; Mokhtar R; Louvet C;
    Gastroenterol Clin Biol; 2004; 28(8-9):645-50. PubMed ID: 15646530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma.
    Maiello E; Gebbia V; Giuliani F; Testa A; Giotta F; Gebbia N; Colucci G
    Clin Ter; 1998; 149(5):351-5. PubMed ID: 10052247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.
    Choi CW; Choi IK; Seo JH; Kim BS; Kim JS; Kim CD; Um SH; Kim JS; Kim YH
    Am J Clin Oncol; 2000 Aug; 23(4):425-8. PubMed ID: 10955877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis.
    Baldini C; Escande A; Bouché O; El Hajbi F; Volet J; Bourgeois V; Renaut Vantroys T; Ploquin A; Desauw C; Hebbar M
    Pancreatology; 2017; 17(1):146-149. PubMed ID: 28040425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
    Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
    Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.